hydration benefits glp-1 receptor agonist therapy Evolution of GLP‐1 Agonists for Diabetes Treatment Glucagon-like peptide-1 receptor agonists and
Description
References: FARXIGA (dapagliflozin) [package insert]

The SURPASS-3 findings showed that people with T2DM can obtain a better glycemic control with tirzepatide than with insulin degludec, while losing weight rather than gaining weight

The underlying mechanisms involve inflammation suppression, oxidative stress reduction, and endothelial function restoration, all of which contribute to improved cardiac performance [52]

iScience 24: 102963

a) Trulicity was approved in 2014 and has been a significantly popular treatment for T2D since
